Clinical Trials in Bellvitge, Spain
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients, Refractory to Lenalidomide
Relapsed Multiple Myeloma
PETHEMA Foundation60 enrolled15 locationsNCT05060627
Recruiting
Not Applicable
Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in Adults
Acute Lymphoblastic Leukemia
PETHEMA Foundation300 enrolled108 locationsNCT04179929